A rapid <it>in situ </it>procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis

<p>Abstract</p> <p>Background</p> <p>Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current clinical practice. Nevertheless, resistant strains increase dramatically, with serious economic impact and effects on public health, a...

Full description

Bibliographic Details
Main Authors: Bou Germán, Gosálvez Jaime, Tamayo María, Santiso Rebeca, Fernández María del Carmen, Fernández José
Format: Article
Language:English
Published: BMC 2011-08-01
Series:BMC Microbiology
Online Access:http://www.biomedcentral.com/1471-2180/11/191
id doaj-9d4053f384374f65b1a3abaefef53c11
record_format Article
spelling doaj-9d4053f384374f65b1a3abaefef53c112020-11-24T22:10:37ZengBMCBMC Microbiology1471-21802011-08-0111119110.1186/1471-2180-11-191A rapid <it>in situ </it>procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesisBou GermánGosálvez JaimeTamayo MaríaSantiso RebecaFernández María del CarmenFernández José<p>Abstract</p> <p>Background</p> <p>Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current clinical practice. Nevertheless, resistant strains increase dramatically, with serious economic impact and effects on public health, and are responsible for thousands of deaths each year. Critical clinical situations should benefit from a rapid procedure to evaluate the sensitivity or resistance to antibiotics that act at the cell wall. We have adapted a kit for rapid determination of bacterial DNA fragmentation, to assess cell wall integrity.</p> <p>Results</p> <p>Cells incubated with the antibiotic were embedded in an agarose microgel on a slide, incubated in an adapted lysis buffer, stained with a DNA fluorochrome, SYBR Gold and observed under fluorescence microscopy. The lysis affects the cells differentially, depending on the integrity of the wall. If the bacterium is susceptible to the antibiotic, the weakened cell wall is affected by the lysing solution so the nucleoid of DNA contained inside the bacterium is released and spread. Alternatively, if the bacterium is resistant to the antibiotic, it is practically unaffected by the lysis solution and does not liberate the nucleoid, retaining its normal morphological appearance. In an initial approach, the procedure accurately discriminates susceptible, intermediate and resistant strains of <it>Escherichia coli </it>to amoxicillin/clavulanic acid. When the bacteria came from an exponentially growing liquid culture, the effect on the cell wall of the β-lactam was evident much earlier that when they came from an agar plate. A dose-response experiment with an <it>E. coli </it>strain susceptible to ampicillin demonstrated a weak effect before the MIC dose. The cell wall damage was not homogenous among the different cells, but the level of damage increased as dose increased with a predominant degree of effect for each dose. A microgranular-fibrilar extracellular background was evident in gram-negative susceptible strains after β-lactam treatment. This material was digested by DNase I, hybridised with a specific whole genome probe, and so recognized as DNA fragments released by the bacteria. Finally, 46 clinical strains from eight gram-negative and four gram-positive species were evaluated blind for susceptibility or resistance to one of four different β-lactams and vancomycin, confirming the applicability of the methodology.</p> <p>Conclusion</p> <p>The technique to assess cell wall integrity appears to be a rapid and simple procedure to identify resistant and susceptible strains to antibiotics that interfere with peptidoglycan biosynthesis.</p> http://www.biomedcentral.com/1471-2180/11/191
collection DOAJ
language English
format Article
sources DOAJ
author Bou Germán
Gosálvez Jaime
Tamayo María
Santiso Rebeca
Fernández María del Carmen
Fernández José
spellingShingle Bou Germán
Gosálvez Jaime
Tamayo María
Santiso Rebeca
Fernández María del Carmen
Fernández José
A rapid <it>in situ </it>procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis
BMC Microbiology
author_facet Bou Germán
Gosálvez Jaime
Tamayo María
Santiso Rebeca
Fernández María del Carmen
Fernández José
author_sort Bou Germán
title A rapid <it>in situ </it>procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis
title_short A rapid <it>in situ </it>procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis
title_full A rapid <it>in situ </it>procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis
title_fullStr A rapid <it>in situ </it>procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis
title_full_unstemmed A rapid <it>in situ </it>procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis
title_sort rapid <it>in situ </it>procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis
publisher BMC
series BMC Microbiology
issn 1471-2180
publishDate 2011-08-01
description <p>Abstract</p> <p>Background</p> <p>Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current clinical practice. Nevertheless, resistant strains increase dramatically, with serious economic impact and effects on public health, and are responsible for thousands of deaths each year. Critical clinical situations should benefit from a rapid procedure to evaluate the sensitivity or resistance to antibiotics that act at the cell wall. We have adapted a kit for rapid determination of bacterial DNA fragmentation, to assess cell wall integrity.</p> <p>Results</p> <p>Cells incubated with the antibiotic were embedded in an agarose microgel on a slide, incubated in an adapted lysis buffer, stained with a DNA fluorochrome, SYBR Gold and observed under fluorescence microscopy. The lysis affects the cells differentially, depending on the integrity of the wall. If the bacterium is susceptible to the antibiotic, the weakened cell wall is affected by the lysing solution so the nucleoid of DNA contained inside the bacterium is released and spread. Alternatively, if the bacterium is resistant to the antibiotic, it is practically unaffected by the lysis solution and does not liberate the nucleoid, retaining its normal morphological appearance. In an initial approach, the procedure accurately discriminates susceptible, intermediate and resistant strains of <it>Escherichia coli </it>to amoxicillin/clavulanic acid. When the bacteria came from an exponentially growing liquid culture, the effect on the cell wall of the β-lactam was evident much earlier that when they came from an agar plate. A dose-response experiment with an <it>E. coli </it>strain susceptible to ampicillin demonstrated a weak effect before the MIC dose. The cell wall damage was not homogenous among the different cells, but the level of damage increased as dose increased with a predominant degree of effect for each dose. A microgranular-fibrilar extracellular background was evident in gram-negative susceptible strains after β-lactam treatment. This material was digested by DNase I, hybridised with a specific whole genome probe, and so recognized as DNA fragments released by the bacteria. Finally, 46 clinical strains from eight gram-negative and four gram-positive species were evaluated blind for susceptibility or resistance to one of four different β-lactams and vancomycin, confirming the applicability of the methodology.</p> <p>Conclusion</p> <p>The technique to assess cell wall integrity appears to be a rapid and simple procedure to identify resistant and susceptible strains to antibiotics that interfere with peptidoglycan biosynthesis.</p>
url http://www.biomedcentral.com/1471-2180/11/191
work_keys_str_mv AT bougerman arapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT gosalvezjaime arapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT tamayomaria arapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT santisorebeca arapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT fernandezmariadelcarmen arapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT fernandezjose arapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT bougerman rapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT gosalvezjaime rapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT tamayomaria rapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT santisorebeca rapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT fernandezmariadelcarmen rapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
AT fernandezjose rapiditinsituitprocedurefordeterminationofbacterialsusceptibilityorresistancetoantibioticsthatinhibitpeptidoglycanbiosynthesis
_version_ 1725807450600243200